Mucosal and systemic anti-GAG immunity induced by neonatal immunization with HIV LAMP/gag DNA vaccine in mice
- PMID: 20870310
- DOI: 10.1016/j.imbio.2010.08.007
Mucosal and systemic anti-GAG immunity induced by neonatal immunization with HIV LAMP/gag DNA vaccine in mice
Abstract
Vaccines capable of inducing mucosal immunity in early postnatal life until adulthood, protecting early sexual initiation, should be considered as strategies to vaccination against HIV. The HIV-1 GAG protein as a chimera with the lysosome-associated membrane protein (LAMP/gag), encoded by a DNA vaccine, is targeted to the endosomal/lysosomal compartment that contains class II MHC molecules and has been shown to be immunogenic in adult mice. Assuming that one such strategy could help to overcome the immunological immaturity in the early postnatal period, we have evaluated the systemic and mucosal immunogenicity of LAMP/gag immunization in neonatal mice. Intranasal immunization with LAMP/gag vaccine induced higher levels of sIgA and IgG anti-GAG antibodies in intestinal washes than did the gag vaccine. The combination of ID injections and the IN protocol with the chimeric vaccine promoted the increase of Ab levels in sera. Both vaccines induced splenic IFN-γ- secreting cells against GAG peptide pools, as well as in vivo cytotoxic T lymphocyte (CTL) function, and increased the percentage of CD8+ T cells to the immunodominant class I peptide in gut and spleen. However, only the chimeric vaccine was able to enhance Th1/Th2 cytokine secretion in response to class II GAG peptide and to enhance IL-4-secreting cells against GAG peptides and p24 protein stimuli. Long-lasting humoral and cellular responses were detected until adult age, following neonatal immunization with the chimeric vaccine. The LAMP/gag vaccination was able to induce potent GAG-specific T and B cell immune responses in early life which are essential to elicit sustained and long-lasting mucosal and systemic humoral response.
Copyright © 2010 Elsevier GmbH. All rights reserved.
Similar articles
-
Immunization of neonatal mice with LAMP/p55 HIV gag DNA elicits robust immune responses that last to adulthood.Virology. 2010 Oct 10;406(1):37-47. doi: 10.1016/j.virol.2010.06.050. Epub 2010 Jul 29. Virology. 2010. PMID: 20667577
-
DNA encoding an HIV-1 Gag/human lysosome-associated membrane protein-1 chimera elicits a broad cellular and humoral immune response in Rhesus macaques.PLoS One. 2006 Dec 27;1(1):e135. doi: 10.1371/journal.pone.0000135. PLoS One. 2006. PMID: 17205139 Free PMC article.
-
Inverted terminal repeat sequences of adeno-associated virus enhance the antibody and CD8(+) responses to a HIV-1 p55Gag/LAMP DNA vaccine chimera.Virology. 2004 Jun 1;323(2):220-32. doi: 10.1016/j.virol.2004.02.025. Virology. 2004. PMID: 15193918
-
Clarification of how HIV-1 DNA and protein immunizations may be better used to obtain HIV-1-specific mucosal and systemic immunity.Expert Rev Vaccines. 2007 Apr;6(2):203-12. doi: 10.1586/14760584.6.2.203. Expert Rev Vaccines. 2007. PMID: 17408370 Review.
-
Multiple Approaches for Increasing the Immunogenicity of an Epitope-Based Anti-HIV Vaccine.AIDS Res Hum Retroviruses. 2015 Nov;31(11):1077-88. doi: 10.1089/AID.2015.0101. Epub 2015 Aug 13. AIDS Res Hum Retroviruses. 2015. PMID: 26149745 Review.
Cited by
-
Enhanced immunogenicity and protective efficacy in mice following a Zika DNA vaccine designed by modulation of membrane-anchoring regions and its association to adjuvants.Front Immunol. 2024 Jan 19;15:1307546. doi: 10.3389/fimmu.2024.1307546. eCollection 2024. Front Immunol. 2024. PMID: 38361945 Free PMC article.
-
LAMP-1 Chimeric to HIV-1 p55Gag in the Immunization of Neonate Mice Induces an Early Germinal Center Formation and AID Expression.Vaccines (Basel). 2022 Aug 3;10(8):1246. doi: 10.3390/vaccines10081246. Vaccines (Basel). 2022. PMID: 36016134 Free PMC article.
-
SIV-Specific Antibodies are Elicited by a Recombinant Fowlpox Virus Co-expressing SIV Gag and envT.Indian J Microbiol. 2018 Sep;58(3):345-352. doi: 10.1007/s12088-018-0728-y. Epub 2018 Apr 27. Indian J Microbiol. 2018. PMID: 30013279 Free PMC article.
-
BAP31, a promising target for the immunotherapy of malignant melanomas.J Exp Clin Cancer Res. 2015 Apr 18;34(1):36. doi: 10.1186/s13046-015-0153-6. J Exp Clin Cancer Res. 2015. PMID: 25903101 Free PMC article.
-
Protective immunity induced by peptides of AMA1, RON2 and RON4 containing T-and B-cell epitopes via an intranasal route against toxoplasmosis in mice.Parasit Vectors. 2015 Jan 13;8:15. doi: 10.1186/s13071-015-0636-5. Parasit Vectors. 2015. PMID: 25582167 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials